Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02852928
What this trial is testing

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Who this might be right for
Lung Diseases, InterstitialPulmonary Alveolar ProteinosisPulmonary Eosinophilia+3 more
Matthias Griese 1,000
Not applicableNot Yet RecruitingNCT07222592
What this trial is testing

MOBoxy: MoblO2 to Maintain Oxygenation

Who this might be right for
COPDInterstitial Lung Disease
National Jewish Health 48
Not applicableStudy completedNCT04572971
What this trial is testing

Reliability and Validity of iOS in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 78
Not applicableLooking for participantsNCT07486206
What this trial is testing

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers 152
Not applicableUnknownNCT05719038
What this trial is testing

Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study

Who this might be right for
Pulmonary FibrosisCOVID-19
Kunming Medical University 200
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Testing effectiveness (Phase 2)WithdrawnNCT01135199
What this trial is testing

Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Stanford University
Not applicableActive Not RecruitingNCT04680832
What this trial is testing

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 600
Early research (Phase 1)Study completedNCT00074698
What this trial is testing

Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 21
Not applicableLooking for participantsNCT06323876
What this trial is testing

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 160
Not applicableStudy completedNCT01982968
What this trial is testing

Treatment of IPF With Laparoscopic Anti-Reflux Surgery

Who this might be right for
Idiopathic Pulmonary FibrosisGastroesophageal Reflux
University of California, San Francisco 58
Large-scale testing (Phase 3)Looking for participantsNCT07816185
What this trial is testing

Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseVascular Diseases+2 more
Pulmovant, Inc. 376
Large-scale testing (Phase 3)Ended earlyNCT00076635
What this trial is testing

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary FibrosisLung Disease
InterMune 91
Not applicableUnknownNCT04019080
What this trial is testing

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Who this might be right for
Idiopathic Pulmonary Fibrosis
Karolinska University Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Not applicableStudy completedNCT02713347
What this trial is testing

Advancing Symptom Alleviation With Palliative Treatment

Who this might be right for
Heart FailurePulmonary Disease, Chronic ObstructiveEmphysema+1 more
VA Office of Research and Development 306
Not applicableActive Not RecruitingNCT07048652
What this trial is testing

Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases

Who this might be right for
Idiopathic Pulmonary Fibrosis
Superior University 68
Not applicableStudy completedNCT00504621
What this trial is testing

The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis

Who this might be right for
SarcoidosisPulmonary Fibrosis
Maastricht University Medical Center 450
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Not applicableActive Not RecruitingNCT07088185
What this trial is testing

Pulmonary Outcomes on Patients With Lung Fibrosis

Who this might be right for
Lung Fibrosis
South Valley University 60
Next Page